# Progress Note 04 — Sick Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Eva Perón (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML025-SYN-TD
- Date: 1951-03-27
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lucía Barragán, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Sick Visit
- Services: Problem-oriented office visit, established patient

## Chief complaint

Burning on passing urine and cloudy urine for two days, in the third week of chemoradiation. **S**

## History of present illness

Ms. Perón called the clinic and was seen the same day, with the visit in Spanish. She is in the third week of pelvic radiation and had her third weekly cisplatin dose four days ago. Since radiation began she has needed to pass urine a little more often, as she was told to expect. For two days she has had new burning, strong urgency, and cloudy, strong-smelling urine. She has had no fever, chills, back or side pain, or vomiting, and no blood in the urine. Her bowels are looser, twice a day, controlled with loperamide; nausea after cisplatin settles with ondansetron. The vaginal bleeding has nearly stopped. She is tired but still working half days. She has been coping, and the social worker has seen her once during treatment. **S**

| Element | Detail |
|---|---|
| Onset | Two days ago |
| Location | Bladder and urethra |
| Character | Burning, urgency, cloudy strong-smelling urine, on top of mild radiation frequency |
| Severity | Discomfort 4 of 10 |
| Context | Third week of pelvic radiation; third weekly cisplatin four days ago |
| Associated signs and symptoms | No fever, flank pain, vomiting, or blood in the urine |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired; no fever or chills |
| Gastrointestinal | Positive | Loose stools twice daily on loperamide; nausea controlled; no abdominal pain |
| Genitourinary | Positive | Burning, urgency, cloudy urine; vaginal bleeding nearly stopped; no flank pain or blood in the urine |
| Psychiatric | Negative | Coping; no thoughts of self-harm |

4 systems reviewed. **S**

## Current medications

- Ferrous sulfate 325 mg (65 mg elemental iron) oral tablet, one tablet by mouth once daily, with vitamin C-rich food or juice, apart from tea and dairy **S**
- Acetaminophen 500 mg oral tablet, one or two tablets by mouth every 6 hours when needed for pelvic pain, no more than 6 tablets a day **S**
- Nitrofurantoin (monohydrate and macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for 5 days **S**
- Cisplatin 40 mg/m2 (64 mg) intravenous infusion once weekly for five weeks during pelvic radiation, with hydration and antiemetic premedication in the infusion center **S**
- Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours when needed for nausea in the days after cisplatin **S**
- Loperamide 2 mg oral capsule, two capsules after the first loose stool, then one after each loose stool, no more than 8 a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 106/66 mmHg; pulse 88 bpm; respirations 16/min; temperature 37.2 °C; oxygen saturation 99% on room air; weight 51.4 kg; BMI 18.9 kg/m². All vital signs are synthetic.

White cells: 4.1 10*3/uL; Neutrophils: 2.6 10*3/uL; Hemoglobin: 10.4 g/dL (low); Platelets: 168 10*3/uL; Creatinine: 0.8 mg/dL; eGFR: 101 mL/min/1.73 m². All results are synthetic.

## Change since baseline

- White cells: 7.1 10*3/uL at baseline, 4.1 10*3/uL at this visit **S**
- Hemoglobin: 9.4 g/dL (low) at baseline, 10.4 g/dL (low) at this visit **S**
- Platelets: 398 10*3/uL at baseline, 168 10*3/uL at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Tired but comfortable; temperature 37.2 °C, pulse 88, blood pressure 106/66 |
| Abdomen | Soft; mild suprapubic tenderness; no other tenderness |
| Back | No costovertebral angle tenderness |
| Skin | Mild redness of the skin in the radiation field; no breakdown |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Acute cystitis during chemoradiation** (N30.00). New burning, urgency and cloudy urine with leukocyte esterase and nitrite on the dipstick point to a bladder infection rather than radiation cystitis alone. No fever or flank pain to suggest kidney infection. The neutrophil count is 2.6 x10^3/uL, so she is not neutropenic, and kidney function is normal (creatinine 0.8 mg/dL, eGFR 101), so nitrofurantoin is suitable. A urine culture was sent because radiation can mimic infection and a clear result guides any recurrence. **S**
   - Nitrofurantoin 100 mg twice daily with food for 5 days.
   - Fluids through the day.
   - Same-day call for fever of 38 °C or more, rigors, flank pain, or vomiting, because she is receiving chemotherapy.
   - Radiation oncology team informed; treatment continues without a break.
   - Culture result by phone.
2. **Squamous cell carcinoma of the cervix, FIGO 1943 stage IIB** (C53.9). On schedule: week three of radiation, three of five cisplatin doses. Blood count adequate for the next dose (hemoglobin 10.4 g/dL, platelets 168). Diarrhea grade 1 on loperamide; nausea controlled. **S**
   - Continue chemoradiation as planned.
   - Continue loperamide and ondansetron as needed.
3. **Iron deficiency anemia** (D50.0). Hemoglobin 10.4 g/dL, holding above 10 during radiation. **S**
   - Continue ferrous sulfate.

## Medication changes

- Started: Nitrofurantoin (monohydrate and macrocrystals) 100 mg oral capsule, one capsule by mouth twice daily with food for 5 days **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer (Version 1.2027), National Comprehensive Cancer Network
- CMID: Clinical Monitoring Intelligence Database, anemia monograph (2026), Aether Forge
- International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases (2010), Infectious Diseases Society of America (Clinical Infectious Diseases)

## Follow-up

- Culture result by phone. Weekly on-treatment review with the oncology team; review here two weeks after brachytherapy. **S**
- Next scheduled visit 1951-05-18: review two weeks after completing chemoradiation and brachytherapy: side effects, menopause symptoms, and survivorship care. **S**
